/PRNewswire/ Biosyngen, an immune-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma treatment, today announced.
New state-of-the-art facility to develop immunotherapy assets to address unmet needs in cancer treatmentSINGAPORE - Media OutReach - 28 June 2023 – Biosyngen, an.
PM Lee receives a first-hand update by Biosyngen on its progress in cell therapy vietreader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vietreader.com Daily Mail and Mail on Sunday newspapers.
Axiata, Digi rise on planned telco operations merger theedgemarkets.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theedgemarkets.com Daily Mail and Mail on Sunday newspapers.